OMC
FULC icon

Old Mission Capital’s Fulcrum Therapeutics FULC Stock Holding History

Old Mission Capital’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,900
Closed -$78.9K – 1391
2023
Q2 		$78.9K Buy
+23,900
New +$70.2K ﹤0.01% 1102
2022
Q1 		– Sell
-20,670
Closed -$366K – 1455
2021
Q4 		$366K Buy
+20,670
New +$409K 0.02% 699

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Old Mission Capital's FULC Position: Q3 2023 in Review

Old Mission Capital sold out of Fulcrum Therapeutics (FULC) in Q3 2023, closing a stake of 23,900 shares — an estimated $78.9K sold.

Old Mission Capital first reported a position in FULC in Q4 2021 and held it in 2 quarters. The position peaked at $366K in Q4 2021. 81 funds tracked by Wall St. Rank hold FULC as of Q3 2023.

  • Old Mission Capital reported no remaining Fulcrum Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Old Mission Capital sold 23,900 Fulcrum Therapeutics shares in Q3 2023, an estimated $78.9K.
  • Old Mission Capital first reported a position in Fulcrum Therapeutics in Q4 2021 and held it in 2 quarters.
  • Old Mission Capital's Fulcrum Therapeutics position peaked at $366K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2023.

Based on Old Mission Capital's 13F filing for Q3 2023, filed 15 Nov 2023.